SHOCK OCCURRENCE AND SURVIVAL IN 49 PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY AND AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR

被引:20
作者
GRIMM, W
MARCHLINSKI, FE
机构
[1] HOSP UNIV PENN,DEPT MED,DIV CARDIOL,CLIN ELECTROPHYSIOL LAB,PHILADELPHIA,PA 19104
[2] PHILADELPHIA HEART INST,SIDNEY KIIMMEL CARDIOVASC RES CTR,PHILADELPHIA,PA
关键词
IDIOPATHIC DILATED CARDIOMYOPATHY; SUDDEN CARDIAC DEATH; SPONTANEOUS SHOCKS; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;
D O I
10.1093/oxfordjournals.eurheartj.a060888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine shock occurrence and survival, 49 patients with idiopathic dilated cardiomyopathy presenting with cardiac arrest (82%), syncope (12%) or ventricular tachycardia without syncope (6%) were followed for 28 +/- 28 months after cardioverter-defibrillator (ICD) implant according to the intention to treat principle. Using the Kaplan-Meier method, the actuarial incidence for any spontaneous shocks was 20%, 58%, and 77%, and the incidence of appropriate shocks was 16%, 49%, and 72% at 1, 3, and 5 years of follow-up, respectively. Only two of 49 study patients (4%) with an active ICD died suddenly during follow-up. Another two patients, however, with an inactive device died suddenly, resulting in a sudden death rate of 2% per year with an active ICD, and 5% per year, according to the intention to treat principle. The incidence of cardiac death from any cause was 8%, 25%, and 35%, and the incidence of total mortality was 14%, 39%, and 49% during 1, 3, and 5 years of follow-up, respectively. There was no difference in the Kaplan-Meier survival curves for shocked vs non-shocked patients. Thus, in this selected patient population with idiopathic dilated cardiomyopathy the majority of patients received 'appropriate' shocks during follow-up, and the sudden death rate with active ICD is low.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 25 条
[1]   SURVIVAL IN PATIENTS WITH DEPRESSED LEFT-VENTRICULAR FUNCTION TREATED BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
AXTELL, K ;
TCHOU, P ;
AKHTAR, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (02) :291-296
[2]   IMPLANTABLE TRANSVENOUS CARDIOVERTER-DEFIBRILLATORS [J].
BARDY, GH ;
HOFER, B ;
JOHNSON, G ;
KUDENCHUK, PJ ;
POOLE, JE ;
DOLACK, GL ;
GLEVA, M ;
MITCHELL, R ;
KELSO, D .
CIRCULATION, 1993, 87 (04) :1152-1168
[3]  
BIGGER JT, 1991, PACE, V14, P883
[4]  
BOCKER D, 1993, J AM COLL CARDIOL, V21, P1638
[5]   THE RATIONALE FOR PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN HIGH-RISK PATIENTS [J].
BRUGADA, P ;
ANDRIES, E .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (03) :547-551
[6]   CLINICAL-EXPERIENCE, COMPLICATIONS, AND SURVIVAL IN 70 PATIENTS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
ECHT, DS ;
ARMSTRONG, K ;
SCHMIDT, P ;
OYER, PE ;
STINSON, EB ;
WINKLE, RA .
CIRCULATION, 1985, 71 (02) :289-296
[7]   6-YEAR CLINICAL-EXPERIENCE WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
EDEL, TB ;
MALONEY, JD ;
MOORE, S ;
MCGUINN, WP ;
GOHN, D ;
WILLIAMS, D ;
WILKOFF, BL ;
MCCARTHY, P ;
MORANT, VA ;
PEARCE, G ;
SIMMONS, TW ;
TROHMAN, R ;
FIRSTENBERG, M ;
CASTLE, LW .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (11) :1850-1854
[8]   LONG-TERM FOLLOW-UP OF PATIENTS WITH NONISCHEMIC DILATED CARDIOMYOPATHY AND VENTRICULAR TACHYARRHYTHMIAS TREATED WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS [J].
FAZIO, G ;
VELTRI, EP ;
TOMASELLI, G ;
LEWIS, R ;
GRIFFITH, LSC ;
GUARNIERI, T .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (11) :1905-1910
[9]   EFFICACY OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN PROLONGING SURVIVAL IN PATIENTS WITH SEVERE UNDERLYING CARDIAC DISEASE [J].
FOGOROS, RN ;
ELSON, JJ ;
BONNET, CA ;
FIEDLER, SB ;
BURKHOLDER, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (02) :381-386
[10]   ACTUARIAL INCIDENCE AND PATTERN OF OCCURRENCE OF SHOCKS FOLLOWING IMPLANTATION OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
FOGOROS, RN ;
ELSON, JJ ;
BONNET, CA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (09) :1465-1473